FR2636948A1 - N-(2-piperidylmethyl)benzamides substitues anti-arythmiques et composition pharmaceutique les contenant - Google Patents

N-(2-piperidylmethyl)benzamides substitues anti-arythmiques et composition pharmaceutique les contenant

Info

Publication number
FR2636948A1
FR2636948A1 FR8912527A FR8912527A FR2636948A1 FR 2636948 A1 FR2636948 A1 FR 2636948A1 FR 8912527 A FR8912527 A FR 8912527A FR 8912527 A FR8912527 A FR 8912527A FR 2636948 A1 FR2636948 A1 FR 2636948A1
Authority
FR
France
Prior art keywords
piperidylmethyl
benzamides
substituted
antiarrhythmic
pharmaceutical composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR8912527A
Other languages
English (en)
Other versions
FR2636948B1 (fr
Inventor
Elden H Banitt
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Riker Laboratories Inc
Original Assignee
Riker Laboratories Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Riker Laboratories Inc filed Critical Riker Laboratories Inc
Publication of FR2636948A1 publication Critical patent/FR2636948A1/fr
Application granted granted Critical
Publication of FR2636948B1 publication Critical patent/FR2636948B1/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/36—Radicals substituted by singly-bound nitrogen atoms
    • C07D213/40—Acylated substituent nitrogen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/26—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by nitrogen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

L'invention concerne des N-(2-pipéridylméthyl)-benzamides substitués nouveaux. Les composés de l'invention répondent à la formule : (CF DESSIN DANS BOPI) dans laquelle Y est un radical organique. L'invention concerne également des compositions pharmaceutiques contenant ces composés nouveaux, qui y jouent le rôle d'agents anti-arythmiques.
FR898912527A 1988-09-26 1989-09-25 N-(2-piperidylmethyl)benzamides substitues anti-arythmiques et composition pharmaceutique les contenant Expired - Fee Related FR2636948B1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/248,814 US4952574A (en) 1988-09-26 1988-09-26 Antiarrhythmic substituted N-(2-piperidylmethyl)benzamides

Publications (2)

Publication Number Publication Date
FR2636948A1 true FR2636948A1 (fr) 1990-03-30
FR2636948B1 FR2636948B1 (fr) 1994-09-30

Family

ID=22940797

Family Applications (1)

Application Number Title Priority Date Filing Date
FR898912527A Expired - Fee Related FR2636948B1 (fr) 1988-09-26 1989-09-25 N-(2-piperidylmethyl)benzamides substitues anti-arythmiques et composition pharmaceutique les contenant

Country Status (3)

Country Link
US (1) US4952574A (fr)
DE (1) DE3931954A1 (fr)
FR (1) FR2636948B1 (fr)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6316627B1 (en) 1997-04-21 2001-11-13 Fine Tech Ltd. Process for the preparation of flecainide
DE19982965B3 (de) * 1998-12-25 2012-08-30 Jnc Corporation Flüssigkristalline Verbindung mit einem negativen Wert der dielektrischen Anisotropie
DE10025700A1 (de) * 2000-05-26 2001-11-29 Merck Patent Gmbh Verfahren zur Herstellung von trifluorethoxysubstituierten Benzoesäuren
US20040220409A1 (en) * 2001-02-20 2004-11-04 Mcdaniel William C Flecainide synthesis
US7244865B2 (en) * 2003-02-24 2007-07-17 Mallinckrodt Inc. Process for preparing benzhydrylthioacetamide
CA2628635C (fr) * 2005-11-08 2017-03-28 Atheris Laboratories Peptides de type mu-conotoxine et leur emploi en tant qu'anesthesique local
LT2797416T (lt) 2011-12-28 2017-10-25 Global Blood Therapeutics, Inc. Pakeistieji benzaldehido junginiai ir jų panaudojimo būdai, didinant audinių aprūpinimą deguonimi
ES2790358T3 (es) 2011-12-28 2020-10-27 Global Blood Therapeutics Inc Compuestos de heteroaril aldehído sustituido y métodos para su uso en el aumento de la oxigenación tisular
MX2015011445A (es) 2013-03-15 2016-04-20 Global Blood Therapeutics Inc Compuestos y usos de estos para la modulacion de la hemoglobina.
KR20150132146A (ko) 2013-03-15 2015-11-25 글로벌 블러드 테라퓨틱스, 인크. 헤모글로빈 조정을 위한 화합물 및 이의 용도
WO2014145040A1 (fr) 2013-03-15 2014-09-18 Global Blood Therapeutics, Inc. Composés aldéhydes substitués et leurs procédés d'utilisation pour accroître l'oxygénation tissulaire
US10266551B2 (en) 2013-03-15 2019-04-23 Global Blood Therapeutics, Inc. Compounds and uses thereof for the modulation of hemoglobin
US8952171B2 (en) 2013-03-15 2015-02-10 Global Blood Therapeutics, Inc. Compounds and uses thereof for the modulation of hemoglobin
AU2014237348C1 (en) 2013-03-15 2019-02-07 Global Blood Therapeutics, Inc. Compounds and uses thereof for the modulation of hemoglobin
US20140274961A1 (en) 2013-03-15 2014-09-18 Global Blood Therapeutics, Inc. Compounds and uses thereof for the modulation of hemoglobin
US9802900B2 (en) 2013-03-15 2017-10-31 Global Blood Therapeutics, Inc. Bicyclic heteroaryl compounds and uses thereof for the modulation of hemoglobin
US9422279B2 (en) 2013-03-15 2016-08-23 Global Blood Therapeutics, Inc. Compounds and uses thereof for the modulation of hemoglobin
US9458139B2 (en) 2013-03-15 2016-10-04 Global Blood Therapeutics, Inc. Compounds and uses thereof for the modulation of hemoglobin
US9604999B2 (en) 2013-03-15 2017-03-28 Global Blood Therapeutics, Inc. Compounds and uses thereof for the modulation of hemoglobin
EA201992707A1 (ru) 2013-11-18 2020-06-30 Глобал Блад Терапьютикс, Инк. Соединения и их применения для модуляции гемоглобина
BR112015032160B1 (pt) 2014-02-07 2021-11-30 Global Blood Therapeutics, Inc Ansolvato cristalino de composto, composição e composição farmacêutica
MA41841A (fr) 2015-03-30 2018-02-06 Global Blood Therapeutics Inc Composés aldéhyde pour le traitement de la fibrose pulmonaire, de l'hypoxie, et de maladies auto-immunes et des tissus conjonctifs
MA43373A (fr) 2015-12-04 2018-10-10 Global Blood Therapeutics Inc Régimes posologiques pour 2-hydroxy-6-((2- (1-isopropyl-1h-pyrazol-5-yl)pyridin-3-yl)méthoxy)benzaldéhyde
TWI663160B (zh) 2016-05-12 2019-06-21 全球血液治療公司 用於合成2-羥基-6-((2-(1-異丙基-1h-吡唑-5-基)-吡啶-3-基)甲氧基)苯甲醛之方法
TW202332423A (zh) 2016-10-12 2023-08-16 美商全球血液治療公司 包含2-羥基-6-((2-(1-異丙基-1h-吡唑-5-基)吡啶-3-基)甲氧基)-苯甲醛之片劑
WO2020072377A1 (fr) 2018-10-01 2020-04-09 Global Blood Therapeutics, Inc. Modulateurs de l'hémoglobine pour le traitement de la drépanocytose

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3900481A (en) * 1974-04-01 1975-08-19 Riker Laboratories Inc Derivatives of pyrrolidine and piperidine
US4005209A (en) * 1974-04-01 1977-01-25 Riker Laboratories, Inc. Antiarrhythmic method utilizing fluoroalkoxy-N-piperidyl and pyridyl benzamides
US4013670A (en) * 1974-04-01 1977-03-22 Riker Laboratories, Inc. Derivatives of pyrrolidine and piperidine
US4097481A (en) * 1976-11-08 1978-06-27 Riker Laboratories, Inc. Tertiary amide derivatives of pyrrolidine and piperidine
US4339587A (en) * 1981-06-08 1982-07-13 Riker Laboratories, Inc. 5-Benzyloxy or 5-hydroxy-2-(2,2,2-trifluoroethoxy)-N-(2-pyridylmethyl)benzamide
US4452983A (en) * 1981-06-08 1984-06-05 Riker Laboratories, Inc. Phenolic derivative

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3342826A (en) * 1964-01-13 1967-09-19 Ile De France Heterocyclic aminoalkyl benzamides
US4071524A (en) * 1976-11-08 1978-01-31 Riker Laboratories, Inc. Derivatives of urea
US4650873A (en) * 1979-03-19 1987-03-17 Riker Laboratories Process for the preparation of a derivative of piperidine
IT1171707B (it) * 1983-09-30 1987-06-10 Babcock Samifi Spa Dispositivo per il raffreddamento dell'olio in una unita' di compressione e, particolarmente, di compressione a vite
US4599434A (en) * 1983-11-15 1986-07-08 Riker Laboratories, Inc. Cyclopentanone derivatives
US4656285A (en) * 1983-11-15 1987-04-07 Riker Laboratories, Inc. Compound 2-acetamidomethyl-6-methoxy-pyridine

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3900481A (en) * 1974-04-01 1975-08-19 Riker Laboratories Inc Derivatives of pyrrolidine and piperidine
US4005209A (en) * 1974-04-01 1977-01-25 Riker Laboratories, Inc. Antiarrhythmic method utilizing fluoroalkoxy-N-piperidyl and pyridyl benzamides
US4013670A (en) * 1974-04-01 1977-03-22 Riker Laboratories, Inc. Derivatives of pyrrolidine and piperidine
US4097481A (en) * 1976-11-08 1978-06-27 Riker Laboratories, Inc. Tertiary amide derivatives of pyrrolidine and piperidine
US4339587A (en) * 1981-06-08 1982-07-13 Riker Laboratories, Inc. 5-Benzyloxy or 5-hydroxy-2-(2,2,2-trifluoroethoxy)-N-(2-pyridylmethyl)benzamide
US4452983A (en) * 1981-06-08 1984-06-05 Riker Laboratories, Inc. Phenolic derivative

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
JOURNAL OF MEDICINAL CHEMISTRY, vol. 20, no. 6, juin 1977, page 821; E.H. BANITT et al.: "Antiarrhythmics. 2. Synthesis and antiarrhythmic activity of N-(piperidylalkyl)trifluorothoxybenzamides" *

Also Published As

Publication number Publication date
DE3931954A1 (de) 1990-03-29
US4952574A (en) 1990-08-28
FR2636948B1 (fr) 1994-09-30

Similar Documents

Publication Publication Date Title
FR2636948A1 (fr) N-(2-piperidylmethyl)benzamides substitues anti-arythmiques et composition pharmaceutique les contenant
FR2603037B1 (fr) (pentamethyl-1,2,2,6,6,6 piperidyl-4 amino)- triazines, leur application comme stabilisants de matieres organiques, et compositions qui en contiennent
DK77090D0 (da) Immunmodulerende azaspiraner
CA2331870A1 (fr) Nouveaux composes cycliques substitues, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
DE69430861D1 (de) N-acylierte 4-aminopiperidin derivate als aktive bestandteile von peripher gefässerweiternden wikstoffen
KR870700620A (ko) 신규 약리학적 화합물
PT98734A (pt) Processo de preparacao de compostos 1,2,5,6-tetra-hidropiridina e de composicoes farmaceuticas que os contem
KR960701049A (ko) 헤테로사이클릭 화합물, 이의 제조방법 및 이의 용도(Heterocyclic compounds and their preparation and use)
ES2174989T3 (es) Pirido(3,2-e)pirazinonas con antiasmatica y procedimiento para su preparacion.
TNSN87086A1 (fr) Derives du nitrofuranne, leur preparation et leur application en therapeutique
PT98735A (pt) Processo de preparacao de compostos azaciclicos e de composicoes farmaceuticas que os contem
ATE157089T1 (de) Derivate von alkanolaminen als kardiovaskuläre mittel
DE3888012T2 (de) Substituierte 4-[1H-Imidazol-1-yl]benzamide als antiarrhythmische Mittel.
RU94038042A (ru) Производные гексагидроазепинов, фармацевтическая композиция на их основе и антипсихотропный агент
FR2608921B1 (fr) Composition pharmaceutique contenant de la ranitidine
MA22343A1 (fr) Compositions type massepain, contenant du psyllium
MX9203140A (es) Derivados de 4 fenil-4(n-(fenil)amido)-piperidina y las composiciones farmaceuticas, asi como el metodo aplicado para tales compuestos.
FR2446819A1 (fr) Derives 6-alkyles d'acide 1,2-dihydro-2-oxonicotinique et composition pharmaceutique les contenant
ATE69220T1 (de) Sechsgliedrige heterocyclische derivate von n'substituiertenn,n'-diacylhydrazinen.
PT89757A (pt) Processo para a preparacao de novos derivados da xantina e de composicoes farmaceuticas que os contem, uteis no tratamento da ulcera peptica
NO870423D0 (no) 5-substituert octahydroindolizin-analgetika-forbindelser og 7-keto-mellomprodukt.
HUP9702348A2 (hu) Új, véralvadásgátló hatású glikozidok és az ezeket tartalmazó gyógyszerkészítmények
FI860074A (fi) Oktahydroindolizinfoereningar anvaendbara som smaertstillande medel.
ATE24716T1 (de) Lenkotrien-antagonisten.
FR2609392B1 (fr) Compositions pharmaceutiques contenant des pyranoquinoleines

Legal Events

Date Code Title Description
ST Notification of lapse